MT-CO1 and mastocytosis: Here, we retrospectively analyzed the prevalence of MC‐mediator release‐associated symptoms triggered by NSAIDs and other COXi in a large series of mastocytosis patients, and compared the clinical and laboratory features of these patients with those of other mastocytosis patients, in order to search for a potentially unique clinical and laboratory profile associated with hypersensitivity to these drugs.